breast cancer Archives
Nov. 9, 2017—Amanda Mathis, chief financial officer of Bridgestone Americas, was just 35 when she first felt a lump in her right breast.
Oct. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.
Oct. 20, 2017—Do you know what it means to be at “high” or “elevated” risk for developing breast cancer? Do you know if you are at high risk?
Sep. 20, 2017—The Think Pink! Breast Cancer Awareness Expo will be held Wednesday, Oct. 4, from 11 a.m. to 1 p.m. in the Light Hall North Lobby.
Aug. 9, 2017—Thanks to advances in treatment, the relative five-year survival rate from all combined subtypes of breast cancer now exceeds 90 percent and yet the disease remains the third leading cause of cancer deaths in the United States after lung and colorectal cancers.
Aug. 3, 2017—Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients.
Jul. 24, 2017—Vanderbilt University engineers find existing human protein is ideal carrier for powerful molecules that can signal tumors to self-destruct.
Jul. 13, 2017—Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies (C2T2), director of the Breast Cancer Research Program and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named director of the Harold C. Simmons Comprehensive Cancer Center and associate dean of Oncology Programs at the UT Southwestern Medical Center in Dallas.